Skip to main content
Report predicts growth for spine biologics market

A Market Research Engine report predicts the worldwide spine biologics market will reach over $2.5 billion by 2022 at a 4.4% growth rate because of technological advancements, demand for minimally invasive surgery, advantages of biologics and new devices, and treatment techniques. Among the key market players are DePuy Spine, Stryker, Medtronic, Smith & Nephew, Zimmer Spine and NuVasive.

Full Story: